April 14, 2021
Chronic care management company Omada Health is rolling out a new tool that uses computer vision technology to help physical therapists virtually measure a patient's movement and range of motion.
The new technology will be integrated into Omada's musculoskeletal (MSK) services and will be able to provide therapists and patients with a set of longitudinal data.
Omada CEO Sean Duffy said that PTs...
April 14, 2021
Omada's new Physician-Guided Care Program is looking to help patients cut down on frequent trips to the doctor with its virtual cardiometabolic clinic, which provides telemedicine consultations to Omada members.
The new service is able to help integrate prescription, medication management, lab orders and patient support. After the company inked a deal with Abbott back in 2019, members using the...
November 3, 2020
New top-line data presented by Omada Health and researchers from the University of Nebraska Medical Center and Wake Forest University suggest that the chronic condition-management company's digital diabetes-prevention program can deliver clinically meaningful blood sugar reduction and weight loss over 12 months.
The PREDICTS randomized controlled trial was first announced in 2018, and enrolled...
October 7, 2020
More digital health tools join the PBM party. Evernorth, a newly-established Cigna subsidiary that now acts as the parent of Express Scripts, announced today several new additions to the pharmacy benefit manager's Digital Health Formulary. Joining the lineup in 2021 will be:
Wildflower Health's app-based women's health offering.
Quit Genius's digital program for smoking and vaping cessation....
September 2, 2020
A new study jointly conducted by digital chronic care management tool Omada and Evidation Health found that patients using Omada’s diabetes management program reduced their A1c level and average of 0.8 over the course of the clinical research.
The study included a total of 195 participants with Type 2 diabetes who had an average baseline A1c of 8.93%. Researchers reported that those participants...
May 19, 2020
Digital chronic-disease-program company Omada Health is leaping into musculoskeletal care thanks to its acquisition of Physera, an app-based platform that includes remote consultations with physical therapists.
Although the deal was announced today, Omada said it will "immediately" begin offering the MSK program to its employer, health plan and individual customers.
“Integrating a digital...
February 14, 2020
A sample of low-income patients engaged with Omada Health’s digital diabetes prevention program (DPP), achieved weight loss but no major difference in HbA1c levels after a year of use, according to study data recently highlighted by the company.
The results — published late last year in the CDC’s Preventing Chronic Disease journal and first previewed at a 2018 public health conference — suggest...
November 14, 2019
Digital chronic care platform Omada is deepening its relationship with Blue Cross and Blue Shield of Minnesota (Blue Cross), inking a new deal that provides the insurer’s commercial plan members access to the startup’s Type 2 diabetes care platform.
As part of yesterday’s news, Blue Cross also announced it would be making a strategic investment in Omada; however, the actual value of this...
October 11, 2019
It’s little secret that chronic conditions are a heavy burden on the healthcare system. Diabetes, heart disease, obesity and others can stick with a patient for decades, often leading to increased spending on disease management programs and costly visits when those efforts aren’t making an impact.
What’s worse, many of the clinical advances of the past decade or so haven’t substantially moved the...
October 10, 2019
Digital chronic disease management company Omada Health has added onto June’s $73 million funding round with a new strategic investment from Intermountain Ventures. The terms of the deal were not disclosed.
WHAT THEY DO
Omada pitches its digital coaching programs as a scalable and convenient approach to chronic disease management. The company’s products address hypertension, Type 2 diabetes,...